Colgate-Palmolive (NYSE:CL) Position Reduced by Swedbank AB

Swedbank AB reduced its position in shares of Colgate-Palmolive (NYSE:CL) by 3.1% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,858,265 shares of the company’s stock after selling 91,794 shares during the quarter. Swedbank AB owned about 0.35% of Colgate-Palmolive worth $259,845,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. FMR LLC grew its position in Colgate-Palmolive by 65.6% during the 3rd quarter. FMR LLC now owns 6,749,275 shares of the company’s stock worth $700,642,000 after purchasing an additional 2,674,807 shares in the last quarter. Barclays PLC grew its stake in shares of Colgate-Palmolive by 38.7% in the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock valued at $793,542,000 after buying an additional 2,132,747 shares in the last quarter. State Street Corp increased its holdings in Colgate-Palmolive by 3.8% in the third quarter. State Street Corp now owns 48,436,276 shares of the company’s stock worth $5,028,170,000 after buying an additional 1,784,411 shares during the last quarter. Nordea Investment Management AB grew its position in Colgate-Palmolive by 32.5% in the fourth quarter. Nordea Investment Management AB now owns 5,091,683 shares of the company’s stock worth $462,121,000 after acquiring an additional 1,247,731 shares in the last quarter. Finally, Jacobs Levy Equity Management Inc. increased its stake in shares of Colgate-Palmolive by 864.1% during the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 777,854 shares of the company’s stock worth $80,749,000 after purchasing an additional 697,168 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on CL shares. TD Cowen lowered their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, January 8th. JPMorgan Chase & Co. decreased their price objective on Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating on the stock in a report on Thursday, January 16th. Barclays reduced their price target on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research report on Friday, January 17th. Wells Fargo & Company reduced their target price on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a report on Tuesday, January 7th. Finally, StockNews.com cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $101.11.

Colgate-Palmolive Stock Up 0.2 %

Shares of CL traded up $0.19 on Wednesday, reaching $90.05. The company’s stock had a trading volume of 229,675 shares, compared to its average volume of 4,881,689. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. The stock has a market capitalization of $73.57 billion, a PE ratio of 25.80, a PEG ratio of 3.59 and a beta of 0.44. The firm has a fifty day moving average of $91.67 and a 200-day moving average of $97.34. Colgate-Palmolive has a twelve month low of $82.68 and a twelve month high of $109.30.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.22%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio is presently 57.31%.

Insider Transactions at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 0.34% of the company’s stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.